BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11844794)

  • 1. Physical interaction of p73 with c-Myc and MM1, a c-Myc-binding protein, and modulation of the p73 function.
    Watanabe K; Ozaki T; Nakagawa T; Miyazaki K; Takahashi M; Hosoda M; Hayashi S; Todo S; Nakagawara A
    J Biol Chem; 2002 Apr; 277(17):15113-23. PubMed ID: 11844794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB.
    Ozaki T; Watanabe K; Nakagawa T; Miyazaki K; Takahashi M; Nakagawara A
    Oncogene; 2003 May; 22(21):3231-42. PubMed ID: 12761493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter.
    Stros M; Ozaki T; Bacikova A; Kageyama H; Nakagawara A
    J Biol Chem; 2002 Mar; 277(9):7157-64. PubMed ID: 11748232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
    Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
    J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activities of p73 splicing variants are regulated by inter-variant association.
    Ueda Y; Hijikata M; Takagi S; Chiba T; Shimotohno K
    Biochem J; 2001 Jun; 356(Pt 3):859-66. PubMed ID: 11389695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression.
    Uramoto H; Izumi H; Ise T; Tada M; Uchiumi T; Kuwano M; Yasumoto K; Funa K; Kohno K
    J Biol Chem; 2002 Aug; 277(35):31694-702. PubMed ID: 12080043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
    Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
    Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of protein kinase A catalytic subunit beta as a novel binding partner of p73 and regulation of p73 function.
    Hanamoto T; Ozaki T; Furuya K; Hosoda M; Hayashi S; Nakanishi M; Yamamoto H; Kikuchi H; Todo S; Nakagawara A
    J Biol Chem; 2005 Apr; 280(17):16665-75. PubMed ID: 15723830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCAF is a coactivator for p73-mediated transactivation.
    Zhao LY; Liu Y; Bertos NR; Yang XJ; Liao D
    Oncogene; 2003 Nov; 22(51):8316-29. PubMed ID: 14614455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
    Kim EJ; Park JS; Um SJ
    J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73.
    Munarriz E; Barcaroli D; Stephanou A; Townsend PA; Maisse C; Terrinoni A; Neale MH; Martin SJ; Latchman DS; Knight RA; Melino G; De Laurenzi V
    Mol Cell Biol; 2004 Dec; 24(24):10593-610. PubMed ID: 15572666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 and p73 in suppression of Myc-driven lymphomagenesis.
    Griesmann H; Schlereth K; Krause M; Samans B; Stiewe T
    Int J Cancer; 2009 Jan; 124(2):502-6. PubMed ID: 18942718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
    Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
    Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
    Stiewe T; Theseling CC; Pützer BM
    J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.